O124 Efavirenz and rifampicin in the South African context: is there a need to dose increase efavirenz with concurrent rifampicin therapy?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-2652
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
O124 Efavirenz and rifampicin in the South African context: is there a need to dose increase efavirenz with concurrent rifampicin therapy? ; volume:11 ; number:1 ; day:10 ; month:11 ; year:2008 ; pages:1 ; date:12.2008
Journal of the International AIDS Society / International AIDS Society ; 11, Heft 1 (10.11.2008), 1, 12.2008
- Urheber
-
Orrell, C.
- Beteiligte Personen und Organisationen
-
Cohen, K.
Ive, P.
Sanne, I.
Wood, R.
SpringerLink (Online service)
- DOI
-
10.1186/1758-2652-11-S1-O9
- URN
-
urn:nbn:de:1111-2016052055381
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Orrell, C.
- Cohen, K.
- Ive, P.
- Sanne, I.
- Wood, R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effekt der Cytochrom P450 3A-Modulatoren Efavirenz, Rifampicin und Voriconazol auf die Midazolamplasmakonzentration unter kontinuierlicher Midazolaminfusion
Neuropsychiatric manifestations among HIV-1 infected African patients receiving efavirenz-based cART with or without tuberculosis treatment containing rifampicin
Substitution of nevirapine for efavirenz in virologically controlled patients intolerant of efavirenz
Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
Rifampicin und Fettstoffwechsel
Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults
Synthesis of Efavirenz via Asymmetric Alkynylation
Airway microecology in rifampicin-resistant and rifampicin-sensitive pulmonary tuberculosis patients
An in vitro study on efavirenz metabolism and the CYP3A-mediated drug interaction of efavirenz and midazolam
Development of a single-tube, low-cost, analytical process to extract, separate and determine efavirenz and rifampicin plasma concentrations in HIV/TB co-infected patients
MazEF-rifampicin interaction suggests a mechanism for rifampicin induced inhibition of persisters
Induktion des Morphinmetabolismus durch Rifampicin
Effekt der Cytochrom P450 3A-Modulatoren Efavirenz, Rifampicin und Voriconazol auf die Midazolamplasmakonzentration unter kontinuierlicher Midazolaminfusion
Neuropsychiatric manifestations among HIV-1 infected African patients receiving efavirenz-based cART with or without tuberculosis treatment containing rifampicin
Substitution of nevirapine for efavirenz in virologically controlled patients intolerant of efavirenz
Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
Rifampicin und Fettstoffwechsel
Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults
Synthesis of Efavirenz via Asymmetric Alkynylation
Airway microecology in rifampicin-resistant and rifampicin-sensitive pulmonary tuberculosis patients
An in vitro study on efavirenz metabolism and the CYP3A-mediated drug interaction of efavirenz and midazolam
Development of a single-tube, low-cost, analytical process to extract, separate and determine efavirenz and rifampicin plasma concentrations in HIV/TB co-infected patients
MazEF-rifampicin interaction suggests a mechanism for rifampicin induced inhibition of persisters
Induktion des Morphinmetabolismus durch Rifampicin
Effekt der Cytochrom P450 3A-Modulatoren Efavirenz, Rifampicin und Voriconazol auf die Midazolamplasmakonzentration unter kontinuierlicher Midazolaminfusion
Neuropsychiatric manifestations among HIV-1 infected African patients receiving efavirenz-based cART with or without tuberculosis treatment containing rifampicin
Substitution of nevirapine for efavirenz in virologically controlled patients intolerant of efavirenz
Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
Rifampicin und Fettstoffwechsel
Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults
Synthesis of Efavirenz via Asymmetric Alkynylation
Airway microecology in rifampicin-resistant and rifampicin-sensitive pulmonary tuberculosis patients
An in vitro study on efavirenz metabolism and the CYP3A-mediated drug interaction of efavirenz and midazolam
Development of a single-tube, low-cost, analytical process to extract, separate and determine efavirenz and rifampicin plasma concentrations in HIV/TB co-infected patients
MazEF-rifampicin interaction suggests a mechanism for rifampicin induced inhibition of persisters